{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR621/SRR621139/SRR621139.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR621/SRR621138/SRR621138.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR621/SRR621140/SRR621140.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Krogan, Cellular & Molecular Pharmacology, University of California, San Francisco"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA182316"],"long_description":["This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series"],"tag":["xref:PubMed:23333304"],"repository":["ENA"],"description_synonyms":["Gene., Human T-Cell Lymphotropic Virus Type III, Human Immunodeficiency Virus, CBF-alpha-2, Human T Lymphotropic Virus Type III, Aml1, AML1, AIDS Virus, HTLV-III, Gene, Human Immunodeficiency, Human, Lymphadenopathy Associated Virus, Cbfa2, EVI-1, PEBP2aB, AIDS, Immunodeficiency Virus, Virus, Pebpb2, AI462102, Human T-Cell Leukemia Virus Type III, aml1-evi-1, cbfa2, evi-1, Human immunodeficiency virus, AIDS virus, Runx-1, Acquired Immune Deficiency Syndrome Virus, aml, CBFB, Human T-Lymphotropic Virus Type III, Pebp2a2, AML1-EVI-1, Nfya, Lymphadenopathy-Associated, Gene Expressions, pea2-beta, Viruses, AIDS Viruses, AMLCR1, Xaml1, Immunodeficiency Viruses, CBFA2, cbfbeta, amlcr1, Human T Cell Leukemia Virus Type III, Expressions, PEBP2b, pebp2ab, aml1, LAV-HTLV-III, XAML, PEA2, pebp2-beta, Pebpa2b, Acquired Immunodeficiency Syndrome Virus, aml-1, pebp2b, AI893578, Lymphadenopathy-Associated Viruses, CBF-B, HIV, Expression, Human Immunodeficiency Viruses, Pebp2, cbf-beta, PEBP2B, Human T Cell Lymphotropic Virus Type III, human immunodeficiency virus infectious disease, Lymphadenopathy-Associated Virus"],"additional_accession":[]},"is_claimable":false,"name":"","description":"CBFb Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression","dates":{"last_updated":"2025-09-24","first_public":"2013-05-31"},"accession":"PRJNA182316","cross_references":{"GEO":["GSE42576"],"PubMed":["23333304"]}}